Related Experiment Video
Updated: Jul 7, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
Impact of the COVID-19 Pandemic on Inpatient Utilization for Acute Neurologic Disease
Alexander Yoo1, Elan L Guterman2, David Y Hwang3
1Department of Medicine, University of Pennsylvania Perlman School of Medicine, Philadelphia, PA, USA.
Insights
The COVID-19 pandemic saw fewer neurologic hospitalizations, with the greatest declines in headache cases. However, procedures for severe neurologic conditions like stroke and those requiring mechanical ventilation increased during this period.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- The Corona Virus 2019 (COVID-19) pandemic initially led to a reduction in hospitalizations across various medical fields.
- Understanding the impact on neurologic conditions is crucial for healthcare planning.
Purpose of the Study:
- To analyze changes in hospitalization rates and procedures for neurologic diseases during the early COVID-19 pandemic.
- To identify specific neurologic conditions with the most significant changes in admission rates.
Main Methods:
- Retrospective observational study using the California State Inpatient Database.
- Comparison of neurologic hospitalization rates and procedure utilization between a control period (Jan 2019-Feb 2020) and the pandemic period (Mar-Dec 2020).
- Negative binomial regression used to calculate incident rate ratios (IRR) for hospitalizations.
Main Results:
- Overall monthly neurologic hospitalizations decreased by 13% during the pandemic (IRR 0.87).
- Headache admissions saw the largest decrease (IRR 0.62), while neurotrauma and neuro-oncologic cases had smaller declines.
- Rates of endovascular thrombectomy for ischemic stroke, gastrostomy, intubation/mechanical ventilation, and tracheostomy increased during the pandemic.
Conclusions:
- The early COVID-19 pandemic was associated with reduced hospitalizations for most neurologic diagnoses.
- There was a concurrent increase in procedures indicative of severe disease among hospitalized neurologic patients.
- Further research is needed to assess the long-term effects on patient outcomes and healthcare costs.
Abstract:
Background and Objective: The initial months of the Corona Virus 2019 (COVID-19) pandemic resulted in decreased hospitalizations. We aimed to describe differences in hospitalizations and related procedures across neurologic disease. Methods: In our retrospective observational study using the California State Inpatient Database and state-wide population-level estimates, we calculated neurologic hospitalization rates for a control period from January 2019 to February 2020 and a COVID-19 pandemic period from March to December 2020. We calculated incident rate ratios (IRR) for neurologic hospitalizations using negative binomial regression and compared relevant procedure rates over time. Results: Population-based neurologic hospitalization rates were 29.1 per 100,000 (95% CI 26.9-31.3) in April 2020 compared to 43.6 per 100,000 (95% CI 40.4-46.7) in January 2020. Overall, the pandemic period had 13% lower incidence of neurologic hospitalizations per month (IRR 0.87, 95% CI 0.86-0.89). The smallest decreases were in neurotrauma (IRR 0.92, 95% CI 0.89-0.95) and neuro-oncologic cases (IRR 0.93, 95% CI 0.87-0.99). Headache admissions experienced the greatest decline (IRR 0.62, 95% CI 0.58-0.66). For ischemic stroke, greater rates of endovascular thrombectomy (5.6% vs 5.0%; P < .001) were observed in the pandemic. Among all neurologic disease, greater rates of gastrostomy (4.0% vs 3.5%; P < .001), intubation/mechanical ventilation (14.3% vs 12.9%, P < .001), and tracheostomy (1.4 vs 1.2%; P < .001) were observed during the pandemic. Conclusions: During the first months of the COVID-19 pandemic there were fewer hospitalizations to varying degrees for all neurologic diagnoses. Rates of procedures indicating severe disease increased. Further study is needed to determine the impact on triage, patient outcomes, and cost consequences.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Acute Coronary Syndrome IV: Interprofessional Care
Encephalitis ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology

